CoChat

Friend or foe: the dichotomous impact of T cells on neuro-de/re-generation during aging

Open access
Coder, Brandon, Wang, Weikan, Wang, Liefeng, Wu, Zhongdao, Zhuge, Qichuan, Su, Dong-Ming · 2017 · Oncotarget
Cited by 36

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Abstract

// Brandon Coder 1,* , Weikan Wang 1,2,* , Liefeng Wang 1,3 , Zhongdao Wu 4 , Qichuan Zhuge 2 and Dong-Ming Su 1 1 Institute of Molecular Medicine, University of North Texas Health Science Center, Fort Worth, TX, USA 2 Zhejiang Provincial Key Laboratory of Aging and Neurological Disease Research, First Affiliated Hospital, Wenzhou Medical University, Wenzhou City, Zhejiang, P. R. China 3 Department of Biotechnology, Gannan Medical University, Ganzhou, P. R. China 4 Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, P. R. China * These authors have contributed equally to this work Correspondence to: Dong-Ming Su, email: // Qichuan Zhuge, email: // Keywords : T-cell immunity; aging; neurodegeneration; immunotherapy Received : August 17, 2016 Accepted : October 05, 2016 Published : October 11, 2016 Abstract The interaction between T cells and the central nervous system (CNS) in homeostasis and injury has been recognized being both pathogenic (CD4 + T-helper 1 - Th1, Th17 and γδT) and ameliorative (Th2 and regulatory T cells - Tregs). However, in-depth studies aimed to elucidate the precise in the aged microenvironment and the dichotomous role of Tregs have just begun and many aspects remain unclear. This is due, not only to a mutual dependency and reciprocal causation of alterations and diseases between the nervous and T cell immune systems, but also to an inconsistent aging of the two systems, which dynamically changes with CNS injury/recovery and/or aging process. Cellular immune system aging, particularly immunosenescence and T cell aging initiated by thymic involution - sources of chronic inflammation in the elderly (termed inflammaging), potentially induces an acceleration of brain aging and memory loss. In turn, aging of the brain via neuro-endocrine-immune network drives total body systemic aging, including that of the immune system. Therefore, immunotherapeutics including vaccination and “protective autoimmunity” provide promising means to rejuvenate neuro-inflammatory disorders and repair CNS acute injury and chronic neuro-degeneration. We review the current understanding and recent discoveries linking the aging immune system with CNS injury and neuro-degeneration. Additionally, we discuss potential recovery and rejuvenation strategies, focusing on targeting the aging T cell immune system in an effort to alleviate acute brain injury and chronic neuro-degeneration during aging, via the “thymus-inflammaging-neurodegeneration axis”.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.12572

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 68 references

Cited by

Metadata

Authors
Coder, B., Wang, W., Wang, L., Wu, Z., Zhuge, Q., & Su, D.-M.
Venue
Oncotarget
Published
2016-10-11
Volume
8
Issue
4
Pages
7116-7137
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2530540379
Cited by
36
References
68
FWCI
1.63
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.